Xtandi Still Faces Likely US Price Cut Even As It Avoids ‘March In’ Proceeding

 
• By Michael McCaughan
  
frying pan
Xtandi may have moved out of the frying pan and out of the fire on pricing. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet